Echo Therapeutics (ECTE) Reports Q2 Loss of $0.97/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Other income (expense), net: 2.61M
Today's EPS Names:
ESCA, LICT, NKSH, More
Financial Fact:
Other income (expense), net: 2.61M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.97), versus ($0.31) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- First Industrial Realty (FR) Tops Q1 EPS by 21c
- Netflix's subscribers, TSMC, Tesla upside - what's moving markets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
